Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase III
Cardio3 BioSciences Successfully Completes Futility Analysis Of Lead Cardiac Cell Therapy, C-Cure(R) 3/30/2015 1:24:15 PM
Teva (TEVA) Reinforces Leadership Position In CNS With Acquisition Of Auspex Pharmaceuticals (ASPX) 3/30/2015 6:19:04 AM
Can-Fite BioPharma (CFBI) Files 2014 Annual Report On Form 20-F 3/30/2015 12:45:03 PM
Sigma-Tau Pharmaceuticals Receives Orphan Drug Designation For EZN-2279 For Treatment Of Adenosine Deaminase--Deficient Severe Combined Immunodeficiency Disease 3/30/2015 11:55:32 AM
BioDelivery Sciences International (BDSI) Clonidine Topical Gel Fails Phase III, Shares Plunge 3/30/2015 8:19:33 AM
Janssen Research & Development Release: New Study Published In JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time To Relapse In Patients With Schizophrenia 3/30/2015 9:04:13 AM
Morphotek Inc. Announces Initiation Of Farletuzumab Study In Patients With First-Relapsed, Platinum-Sensitive Ovarian Cancer With Low Levels Of The Immunosuppressive CA125 Tumor Antigen 3/30/2015 9:02:15 AM
Can-Fite BioPharma (CFBI) Reports Top-Line Results From Phase II/III Trial For CF101 In Treatment Of Psoriasis 3/30/2015 8:59:05 AM
Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3/30/2015 6:05:06 AM
GENFIT (ALGFT)'s GFT505 Misses Target in Phase IIB But Hopes to Proceed to Phase III 3/27/2015 7:05:21 AM
Relypsa (RLYP) Presents Sub-Group Analysis From Phase 3 Study Of Patiromer FOS In Patients With Advanced Chronic Kidney Disease At 2015 National Kidney Foundation Spring Clinical Meeting 3/27/2015 6:43:09 AM
Results Of Auspex Pharmaceuticals (ASPX)' Phase 3 Registration Trial Of SD-809 To Be Presented At American Academy of Neurology Annual Meeting 3/27/2015 6:09:54 AM
Galderma Announces Positive Outcome Of European Decentralised Procedure For Approval Of Soolantra (Ivermectin) Cream 10mg/G For Rosacea Patients 3/27/2015 9:39:20 AM
Northwest Biotherapeutics (NWBO) Reports Promising Survival Data In 51 Gbm Patients Treated With Dcvax-L 3/27/2015 7:24:57 AM
NephroGenex (NRX) Announces Data On Acute Kidney Injury At National Kidney Foundation 2015 Spring Clinical Meetings 3/27/2015 10:19:26 AM
1234567
//-->